Triple-dose regimen may permanently clear HIV in infected newborns
The reporting (7)
- CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques fiercebiotech.com · 5d ago
- ENABLE project launches to evaluate the enhancement of treatment of HIV in infants by adding monoclonal antibodies IAVI · 5d ago
- Triple-Dose Regimen May Clear HIV in Newborns Scientific Frontline · 5d ago
- Early Research Suggests Triple Therapy Could Clear HIV in Newborns Inside Precision Medicine · 5d ago
- OHSU Study: New, three-pronged treatment clears HIV in infants The Lund Report · 5d ago
- Combination therapy with broadly neutralizing antibodies, antiretroviral therapy and CCR5 blockade limits viral reservoir seeding in infant macaque model of HIV nature.com · 5d ago
- Triple-dose regimen may permanently clear HIV in infected newborns Medical Xpress · 5d ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Column
A surge of August‑14 columns ties brain‑healthy habits to the future wellbeing of aging Americans
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
A breakthrough blood test promises earlier Alzheimer’s diagnosis, yet patients grapple with rising confusion and distress.
Column | 3 minutes of this activity may cut the risk of 13 cancers, study finds
A three‑minute burst of vigorous movement could slash the odds of thirteen cancers, upending the idea that only long workouts protect health.
Fact check: Trump makes numerous false and misleading claims about vaccines and autism
Recent coverage fact-checks numerous false vaccine and autism claims pushed by Donald Trump.
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.